US Patent 7582744 Chemically modified oligonucleotides
Patent 7582744 was granted and assigned to Alnylam Pharmaceuticals on September, 2009 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7582744 Chemically modified oligonucleotides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.